Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Axogen IncTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 31.4× Axogen Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNREGN
Market Cap
$2.61B$82.06B
Sector
TechnologyHealth
52-Week High
$48.48$812.27
52-Week Low
$14.16$555.51
Enterprise Value
$2.52B$76.77B
Dividend Yield
0.47%

Returns comparison

Trailing returns across standard periods

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN